CRT Capital Upgrades Amedisys (AMED) to Fairly Valued
Tweet Send to a FriendGet Alerts AMED Hot Sheet
Price: $11.27 +1.35%
Rating Summary:
0 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
0 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade AMED Now!
CRT Capital upgraded Amedisys (NASDAQ: AMED) from Sell to Fairly Valued.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $13.75 yesterday, with a 52 week range of $9.12-$35.59.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $13.75 yesterday, with a 52 week range of $9.12-$35.59.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
- UPDATE: BofA/Merrill Lynch Upgrades J. C. Penney (JCP) to Neutral
- KeyBanc Upgrades Cedar Shopping Centers (CDR) to Hold
Create E-mail Alert Related Categories
Upgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
